News & Updates

Treatment with delgocitinib ointment, a topical Janus kinase (JAK) inhibitor, for paediatric atopic dermatitis (AD) is effective and well tolerated when applied for up to 56 weeks, according to a phase III trial and a subsequent open-label, long-term study in Japan.

Children who survived central nervous system (CNS) infections experience many endocrinologic imbalances, according to a study. Of these infections, meningitis poses the highest risk of subsequent endocrinopathies, particularly short stature.